Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Clinical Status: Both peptides have been evaluated in early human trials for GH deficiency and metabolic research
Hypoglycaemia (low blood glucose) can occur, particularly when tirzepatide is used in combination with insulin or sulphonylureas
Use within 21-30 days
At PrimeHealth Primary Care, our team is committed to helping patients regulate appetite, reduce cravings, and build lasting lifestyle changes for healthier living
GLP-1 medication coverage depends on your specific plan
Obesity with hepatic steatosis : Patients with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities) and documented fatty liver may benefit from GLP-1 agonists approved for chronic weight management
US$ 22.29
US$ 23.87
US$ 23.68
US$ 20.15
US$ 23.37
US$ 28.33
